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sera (m±SD: 789±211 vs 501±98 OD ×1000; p<0.0001). At the same
time kOA patients had signiﬁcantly higher serum EM-IgG levels: 71% AII
(m±SD: 409±111 vs 274±84; p<0.0005), 59% VEGF (m±SD: 669±241 vs
471±189; p<0.0003), 35% bFGF (m±SD: 689±245 vs 455±115; p<0.009).
Serum BK-IgG overexpression in kOA patients were positively associated
with destructive changes (K&L>4; r=0.75; p<0.005). kOA patients in whom
K&L scores progress rapidly tend to have higher serum BK-IgG levels at all
time point. Elevated serum BK-IgG level was signiﬁcantly correlated with
enhanced pain (r=0.85; p<0.0001) and loss of functions (r=0.69; p<0.0003)
in kOA patients. At the same time kOA patients had signiﬁcantly lower
serum EM-IgM levels relative to normal sera: 66% AII (m±SD: 289±99 vs
455±101; p<0.0001), 79% VEGF (m±SD: 366±181 vs 559±198; p<0.005),
61% bFGF (m±SD: 521±222 vs 705±239; p<0.007). No signiﬁcant differ-
ence in binding of serum EM-IgA levels in kOA patients in comparison with
that in control. No correlations were found to conventional parameters for
pain and function with expression of EM-IgA, EM-IgM.
Conclusions: We showed that our ELISA was able to demonstrate immune
responses to each of the 4 type speciﬁc self-antigens in kOA patients. EM
represent a group of novel selfantigens which are targeted by NA from kOA
patients. Serum NA proﬁling is a promising approach for early detection
and diagnosis of kOA.This results show a speciﬁc dysbalance of Ig content
in kOA patients. Circulating BK-IgG in the sera has been proposed as a
sensitive and speciﬁc marker of diagnosing kOA at early stages of the
disease. Our results have potential applications for controlling unwanted
angiogenesis, inﬂammation, infection, pain and future response to therapy
in kOA patients.
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CONTRIBUTION OF HIGH MOBILITY GROUP BOX 1 TO SYNOVITIS IN
OSTEOARTHRITIS
I. Garcia-Arnandis1 , M. Guillén1,2, F. Gomar1, J.-P. Pelletier3,
J. Martel-Pelletier3, M. Alcaraz1
1Univ. of Valencia, Burjasot, Spain; 2Cardenal Herrera-CEU Univ., Moncada,
Spain; 3Univ. of Montreal Hosp. Res. Ctr. (CRCHUM), Montreal, QC, Canada
Purpose: Extracellular release of High Mobility Group Box 1 (HMGB1) may
exert pro-inﬂammatory activity in rheumatoid arthritis. However, the role
of HMGB1 during the progression of synovitis in osteoarthritis (OA) re-
mains unclear. We have recently demonstrated that IL-1β induces HMGB1
secretion by OA synoviocytes, suggesting the contribution of HMGB1 to
the pro-inﬂammatory effects elicited by IL-1β. In this study, we have
evaluated the effects of HMGB1 in OA synovitis and the signaling pathways
involved.
Methods: Synovial tissue samples were obtained from 15 OA patients
undergoing total knee joint replacement and 3 normal donors. HMGB1
expression was determined in both normal and OA human synovium by
immunohistochemistry and confocal microscopic procedures. OA synovio-
cytes were treated with human recombinant HMGB1 (15-25 ng/ml) in
presence or absence of IL-1 β (10 ng/ml). Gene expression was analyzed
by quantitative PCR and protein expression by Western Blot and ELISA.
MMP activity was determined by ﬂuorometric procedures and activation of
NF-κB by magnetic transfection of the reporter construct NF-κB-luc.
Results: Despite HMGB1 distribution in both normal and OA synovium
was similar (lining, sublining and vascular wall cells), the number of
HMGB1 positive cells was higher in OA, though it was also present in
inﬁltrated cells. Regarding to HMGB1 intracellular localization, we observed
that HMGB1 was mostly found in the nucleus of normal synovium cells,
whereas in OA the localization was markedly cytoplasmic. Treatment of
synoviocytes with 15 or 25 ng/ml of HMGB1 did not modify the production
of IL-6, IL-8, CCL2, CCL20 and matrix metalloproteinases (MMP)-1, 3 and
13). However, the concomitant treatment of HMGB1 with IL-1β signiﬁ-
cantly enhanced, in a dose dependent manner, both mRNA and protein
expression of these mediators, as well as MMP-activity. In addition, HMGB1
potentiated the phosphorylation of Akt, ERK 1/2 and p38 induced by IL-1β
as well as NF-κB activation.
Conclusions: Synovial HMGB1 expression is higher in OA, with a marked
cytoplasmic localization. HMGB1 can act in synergy with IL-1β, with the
consequent increase in the production of several pro-inﬂammatory and
degenerative mediators, thus contributing to synovitis progression during
OA.
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AN INCREASE IN INFLAMMATORYMARKERS IN PEOPLE WITH KNEE
OSTEOARTHRITIS IS RELATED TO PAIN AND ALTEREDWALKING PATTERN
P. Levinger1, M. Trenerry2, I. Levinger3, J. Feller1, J. Bartlett4, N. Bergman5,
M. McKenna6, D. Cameron-Smith2
1La Trobe Univ., Melbourne, Australia; 2Sch. of Exercise and Nutrition Sci.,
Deakin Univ., Melbourne, Australia; 3Sch. of Sport and Exercise Sci., Inst. of
Sport, Exercise and Active Living, Melbourne, Australia; 4Warringal Med. Ctr.,
Melbourne, Australia; 5Warringal Med. Ctr., Melbourne, Australia; 6Inst. of
Sport, Exercise and Active Living, Victoria Univ., Melbourne, Australia
Purpose: Knee osteoarthritis (OA) is a major cause of pain and functional
disability among older people. People with knee OA tend to modify their
walking pattern to reduce pain and joint load. In addition, patients with OA
are characterised by increased inﬂammation and sensitised nerves, result-
ing in increased pain. It is unclear however if the increase in inﬂammatory
markers is related to gait characteristics, particularly knee function during
walking. The aim of this study was to examine the association between
inﬂammatory markers and pain, gait and functional parameters in people
with severe knee OA.
Methods: Nineteen patients (mean ± SEM, age 69.9±1.5 year and BMI
=29.9±0.9 kg·m-2) with severe knee OA scheduled for knee replacement
surgery participated in the study. Knee sagittal motion and moments
during walking were measured using three dimensional motion analysis
system (Vicon). The physical function, pain and stiffness were assessed
using the Western Ontario and McMaster University Osteoarthritis In-
dex. The pain level during walking and the physical activity were also
recorded using Visual analog scale (VAS 0-100mm) and The Incidental
and Planned Activity Questionnaire respectively. Muscle samples from the
vastus lateralis were taken from patients with knee OA during their knee
replacement surgery. Real-time PCR (RT-PCR) was performed to measure
the mRNA abundance of the pro-inﬂammatory cytokines; MCP-1, TNF-α,
IL-1β. The association between peak knee ﬂexion and extension motion
and moments during the stance phase of walking, pain, function and
physical activity was assessed using Pearson correlation coeﬃcient. Seven-
teen age-matched asymptomatic (MA) older people (age= 66.7±1.8 year,
BMI=29.8±1.2 kg·m-2) were used to compare gene analysis data.
Results: OA patients had signiﬁcantly greater mRNA levels of the pro-
inﬂammatory cytokines MCP-1 and TNF-α compared to MA individuals.
OA also tended to have higher levels of IL-1β compared to MA individ-
uals. Increases in pain were correlated with increases in atrogin-1 and
MCP1 (r=0.46, p=0.03; r=0.43, p=0.04, respectively). Increases in planned
physical activity was correlated with MCP-1 (r=0.46, p=0.03) and IL-1β
(r=0.43, p=0.04). TNF-α and IL-1β were signiﬁcantly correlated with peak
knee extension (r=0.54, p=0.01, r=-0.60, p≤0.001, respectively) and ﬂexion
moments (r= -0.56, p≤0.001; r=-0.49, p=0.02 respectively). Increase in IL-1β
mRNA expression was also correlated with reduced knee ﬂexion motion
during stance (r=-0.41, p=0.040. Moreover, MCP-1 was correlated with peak
knee extension moment (r=-0.50, p=0.02).
Conclusions: There is an association between increased inﬂammatory
markers and increase in pain and physical activity. Further, the results
indicate that lower knee ﬂexion moment and larger knee extension mo-
ments were correlated with increase in the inﬂammatory markers. This
gait pattern suggests that people with knee OA tend to reduce the load
over the knee joint by reducing their knee ﬂexion motion in an attempt
to minimise quadriceps use. While a causal relationship has not been
established, the unloading pattern may be a compensatory strategy related
to the presence of inﬂammatory markers. Investigation of the muscle
breakdown biomarkers is needed to better understand their role in muscle
function during walking in people with knee OA.
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SYNOVIAL INFLAMMATION IN PATIENTS UNDERGOING ARTHROSCOPIC
MENISECTOMY: MOLECULAR CHARACTERIZATION AND RELATIONSHIP
WITH SYMPTOMS
C.R. Scanzello1, B. McKeon2, B. Swaim2, E. DiCarlo3, E. Umoh3, V. Kanda1,
A. Nair1, D.M. Lee4, J.C. Richmond2, M.K. Crow3, S.R. Goldring3
1Rush Univ. Med. Ctr., Chicago, IL; 2New England Baptist Hosp., Boston, MA;
3Hosp. for Special Surgery, New York, NY; 4Brigham and Women’t Hosp.,
Boston, MA
Purpose: Anatomic features have been used to distinguish between trau-
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matic and degenerative meniscal tears. Despite proposed differences in
etiology, both patterns are associated with development of osteoarthritis
(OA). In established OA, synovitis is associated with pain and progression,
but a relationship between synovitis and symptoms in isolated meniscal
disease has not been previously investigated. The present studies were
undertaken to characterize synovial pathology in patients with traumatic
meniscal injuries and determine the relationship between inﬂammation,
meniscal and cartilage pathology, and symptoms.
Methods: Thirty-three patients without evidence of OA undergoing athro-
scopic menisectomy for traumatic meniscal injuries were recruited. Pain
and function were assessed preoperatively using three different outcome
scores: the Lysholm score (a knee-speciﬁc metric of pain and disability), the
SF-12, and a visual analog pain scale. Meniscal and cartilage abnormalities
were documented at the time of surgery. Inﬂammation was scored on syn-
ovial biopsies and associations between inﬂammation and clinical outcome
scores determined. Gene expression analysis using microarray technology
was performed comparing patients with and without inﬂammation, to
identify gene products that contribute to development of inﬂammation.
Microarray results were validated using quantitative real-time PCR.
Results: Synovial inﬂammation was present in 42% of the patients and was
associated with worse pre-operative pain and function scores, independent
of age, gender, or cartilage pathology. Microarray analysis and real-time
PCR revealed a chemokine signature in synovial biopsies with increased
inﬂammation scores.
Conclusion: In patients with traumatic meniscal injury undergoing arthro-
scopic menisectomy without clinical or radiographic evidence of OA,
synovial inﬂammation was a frequent ﬁnding and was associated with
increased pain and dysfunction. Synovial inﬂammation was associated with
increased expression of chemokines involved in lymphocyte recruitment.
These chemokines could have implications for development of synovial
inﬂammation in patients with meniscal pathology and represent potential
therapeutic targets to reduce inﬂammatory symptoms.
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THE INFRAPATELLAR FAT PAD SHOULD BE CONSIDERED AS AN ACTIVE
OSTEOARTHRITIC JOINT TISSUE
S. Clockaerts1 , Y.M. Bastiaansen-Jenniskens2, G.V. Van Osch2, J.F. Van
Offel1, J.A. Verhaar2, L.S. De Clerck1, J. Somville1
1Univ. of Antwerp, Edegem, Antwerp, Belgium; 2Erasmus MC, Univ. Med. Ctr.,
Rotterdam, Netherlands
Purpose: Osteoarthritis (OA) of the knee joint may be caused by inﬂam-
mation, in combination with biomechanical alterations. It is characterized
by a loss of articular cartilage, synovial inﬂammation and subchondral
bone sclerosis. Considerable evidence indicates that the menisci, ligaments,
periarticular muscles and the joint capsule are also involved in the OA
process. The purpose of this study is to provide a theoretical framework for
investigating the infrapatellar fat pad as an additional joint tissue involved
in the development and progression of knee-OA by performing a narrative
review of literature. To reinforce this framework, we aim to demonstrate
that macrophages are present in the human infrapatellar fat pad and that
the production of cytokines by the infrapatellar fat pad can be stimulated
in vitro in an explant culture model.
Methods: A literature search was performed in Pubmed considering publi-
cations from 1948 untill October 2009 with keywords infrapatellar fat pad,
Hoffa fat pad, intraarticular adipose tissue, knee, cartilage, bone, cytokine,
adipokine, inﬂammation, growth factor, arthritis, osteoarthritis. Explants of
the infrapatellar fat pad were obtained from 2 OA patients that underwent
total knee arthroplasty. Explants were cultured in DMEM-high glucose
and ITS with or without 10 ng/ml Il-1β as a pro-inﬂammatory stimulus.
Gene expression was analyzed for MCP-1, Il-6, Il-10 and TNF-α and im-
munohistochemical analysis of explants with CD68 and CD206, markers for
macrophages, was performed.
Results: The infrapatellar fat pad is situated intracapsularly and extrasyn-
ovially in the knee joint. Besides adipocytes, the infrapatellar fat pad
contains macrophages, lymphocytes and granulocytes, which are able to
contribute to the disease process of knee-OA. Furthermore, the infrapatellar
fat pad contains nociceptive nerve ﬁbers that could in part be responsible
for anterior pain in knee-OA. These nerve ﬁbers secrete substance P,
which is able to induce inﬂammatory responses and cause vasodilation,
which may lead to infrapatellar fat pad edema and extravasation of the
immune cells. The infrapatellar fat pad secretes cytokines, interleukins,
growth factors and adipokines that inﬂuence cartilage by upregulating the
production of matrix metalloproteinases, stimulating the expression of pro-
inﬂammatory cytokines and inhibiting the production of cartilage matrix
proteins. The infrapatellar fat pad may also stimulate the production of
pro-inﬂammatory mediators, growth factors and matrix metalloproteinases
in synovium. The infrapatellar fat pad may be inﬂuenced by inﬂammatory
cytokines in the synovial ﬂuid of osteoarthritic joints, since we were
able to stimulate the gene expression of MCP-1 (p<0.001), Il-6 (p<0.001),
TNF-α (p=0.01) and Il-10 (p=0.10) in explants from the infrapatellar fat
pad by the addition of 10 ng/ml Il-1β. Immunohistochemical analysis of
infrapatellar fat pad explants revealed the presence of CD68+ and CD206+
cells.
Conclusions: These data are consistent with the hypothesis that the infrap-
atellar fat pad is an active osteoarthritic joint tissue capable of modulating
inﬂammatory and destructive responses in knee-OA. It should be further
investigated in search for new therapeutic strategies.
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SYNOVIAL EXPRESSION OF CANONICAL WNT INDUCES CHONDROCYTE
PHENOTYPE CHANGE AND OA-LIKE CARTILAGE DAMAGE
A.B. Blom, P.L. van Lent, M. van den Bosch, H.M. van Beuningen, F.A. van de
Loo, E.N. Blaney Davidson, P.M. van der Kraan, W.B. van den Berg
Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands
Purpose: Although damage of cartilage and bone are the main patho-
logical features in osteoarthritis (OA), a signiﬁcant involvement of the
synovium has been demonstrated in a large proportion of OA-patients.
The consequences for this synovial involvement in OA pathology are
not yet known. OA incidence is associated with polymorphisms of genes
from the wnt/β-catenin pathway, a pathway that is involved in cartilage
development. In addition, TGFβ-signaling is critical for cartilage integrity.
The aim of the present study is to investigate the contribution of the syn-
ovium to OA pathology via the production of wnts, and whether synovial
wnt-production may lead to skewing of TGFβ-signaling from the protective
smad-2 pathway to the smad1,5,8 pathway, which can induce chondrocyte
hypertrophy.
Methods: Wnt-expression was determined in 2 murine models for OA, one
with clear synovial involvement, collagenase induced (CIOA), and sponta-
neous OA in STR/ort mice, which shows less synovial involvement. CIOA
was generated by intra-articular injection of collagenase, which induces
joint instability. Targets were selected for the generation of adenoviral
vectors to overexpress speciﬁc genes. To study the effect of these genes on
chondrocytes, human chondrocytes were isolated from cartilage that was
obtained from joint replacement surgery and stimulated with wnt3a and/or
TGFβ. Western Blot analysis was performed to detect phosphorylation of
smad1,5,8, which can drive chondrocytes to terminal differentiation. In
vivo effects were determined by intra-articular injection of the viral vectors
and determining joint pathology by histology at several time points after
injection.
Results: Strong upregulation of the canonical wnt16 (up to 256-fold) and
wnt2b (up to 90-fold) was found in both models. Induction of expres-
sion of wnt-proteins was solely found in the synovium, not in cartilage.
However, clear intracellular accumulation of β-catenin was found in both
synovium and cartilage, which indicates the activation of wnt/β-catenin in
both tissues. Wnt-1 induced signaling protein (WISP1), a protein down-
stream canonical wnt signaling, was highly expressed in both tissues, again
indicating activation of this pathway. To determine whether canonical
wnt expression in the synovium can cause cartilage damage, wnt8a was
overexpressed speciﬁcally in the synovium by intra-articular injection of
an adenoviral vector. At day 1 and 3, no changes in the cartilage were
observed. Remarkably, at day 7, a strong induction of cartilage pathology
was observed at the medial margin of the medial tibial plateau, a pref-
erential site for the start of cartilage damage in our models. Incidence of
these lesions was 17% (n=12) in joints with control virus, and 92% (n=12) in
joints that overexpressed canonical wnt8a. This shows that expression of
canonical wnt in the synovium causes cartilage degeneration. Due to their
size, wnt proteins and WISP1 can reach the chondrocytes in the cartilage
matrix and may alter the chondrocyte phenotype. Overexpression of wnt8,
wnt16 and WISP1 in human chondrocytes led to a signiﬁcant increase
within 14 days of collagen type I, and a signiﬁcant decrease of collagen type
II expression, suggesting loss of the chondrocyte phenotype. Preincubation
of chondrocytes with canonical wnts led to the prolonged phosphorylation
of smad1,5,8 after TGFβ stimulation which indicates a change in TGFβ
signaling from protective to hypertrophy-inducing.
